A new rating scale for Alzheimer's disease
- PMID: 6496779
- DOI: 10.1176/ajp.141.11.1356
A new rating scale for Alzheimer's disease
Abstract
A new rating instrument, the Alzheimer's Disease Assessment Scale, was designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic of persons with Alzheimer's disease. Item descriptions, administration procedures, and scoring are outlined. Twenty-seven subjects with Alzheimer's disease and 28 normal elderly subjects were rated on 40 items. Twenty-one items with significant intraclass correlation coefficients for interrater reliability (range, .650-.989) and significant Spearman rank-order correlation coefficients for test-retest reliability (range, .514-1) constitute the final scale. Subjects with Alzheimer's disease had significantly more cognitive and noncognitive dysfunction than the normal elderly subjects.
Similar articles
-
[Spanish adaptation of the Alzheimer's disease assessment scale (ADAS)].Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1994 Mar-Apr;22(2):64-70. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1994. PMID: 8079673 Spanish.
-
A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease.Am J Psychiatry. 1993 Dec;150(12):1806-12. doi: 10.1176/ajp.150.12.1806. Am J Psychiatry. 1993. PMID: 8238634
-
The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.Int J Geriatr Psychiatry. 2006 Mar;21(3):259-65. doi: 10.1002/gps.1457. Int J Geriatr Psychiatry. 2006. PMID: 16477580
-
Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.J Clin Psychiatry. 1998;59 Suppl 13:23-30. J Clin Psychiatry. 1998. PMID: 9771827 Review.
-
Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease.Int Psychogeriatr. 2008 Feb;20(1):1-16. doi: 10.1017/S1041610207006412. Int Psychogeriatr. 2008. PMID: 18072981 Review. No abstract available.
Cited by
-
Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy.Neuropsychol Rev. 2013 Mar;23(1):48-62. doi: 10.1007/s11065-013-9227-4. Epub 2013 Feb 12. Neuropsychol Rev. 2013. PMID: 23400790 Free PMC article. Review.
-
Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease.Drugs Aging. 2013 Jun;30(6):439-45. doi: 10.1007/s40266-013-0070-3. Drugs Aging. 2013. PMID: 23512718 Free PMC article.
-
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.Nat Med. 2021 Jun;27(6):1034-1042. doi: 10.1038/s41591-021-01348-z. Epub 2021 May 24. Nat Med. 2021. PMID: 34031605
-
Health-related resource use and costs in elderly adults with and without mild cognitive impairment.J Am Geriatr Soc. 2013 Mar;61(3):396-402. doi: 10.1111/jgs.12132. Epub 2013 Feb 15. J Am Geriatr Soc. 2013. PMID: 23414481 Free PMC article.
-
Over-Prescribed Medications, Under-Appreciated Risks: A Review of the Cognitive Effects of Anticholinergic Medications in Older Adults.Mo Med. 2016 May-Jun;113(3):207-14. Mo Med. 2016. PMID: 27443047 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical